Purchases and Sales Made in Q3 2022 in Aadi Bioscience, Inc. (AADI)
This table provides information about the institutional ownership of Aadi Bioscience, Inc. (AADI) during Q3 2022. The information is specifically focused on institutions that hold shares of Aadi Bioscience, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-17.9K- 40.96% |
$215K - $254K
|
25.8K
$72.9K
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-17.9K- 40.96% |
$215K - $254K
|
25.8K
$72.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-20.4K- 39.11% |
$245K - $290K
|
31.7K
$89.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-44.2K- 4.89% |
$531K - $628K
|
859K
$2.43M
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-55.3K- 17.74% |
$665K - $787K
|
256K
$726K
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-92.7K- 11.11% |
$1.11M - $1.32M
|
741K
$2.1M
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-286K- 53.31% |
$3.44M - $4.06M
|
250K
$708K
|